₹ 38.28 Cr
1.01%
NIFTY Pharma TRI
INF109KC18L6
1000.0
1000.0
500
Kayzad Eghlim, Nishit Patel, Kewal Shah, Priya Sridhar
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
ICICI Prudential Nifty Pharma Index Fund - Growth | 49.16 | - | - |
Nifty Pharma TRI | 52.24 | 11.6 | 17.72 |
Equity
Debt
Others
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 24.91 |
Dr. Reddy's Laboratories Ltd. | 11.6 |
Cipla Ltd. | 11.28 |
Divi's Laboratories Ltd. | 7.83 |
Lupin Ltd. | 6.1 |
Aurobindo Pharma Ltd. | 4.98 |
Alkem Laboratories Ltd. | 3.73 |
Torrent Pharmaceuticals Ltd. | 3.71 |
Zydus Lifesciences Ltd. | 3.71 |
Ipca Laboratories Ltd. | 2.77 |
Sector | Holdings (%) |
---|---|
Healthcare | 99.95 |
Others | 0.05 |